Vaxcyte Stock Technical Analysis
| PCVX Stock | USD 53.40 0.67 1.27% |
As of the 27th of January, Vaxcyte has the Semi Deviation of 2.25, risk adjusted performance of 0.1031, and Coefficient Of Variation of 768.69. In relation to fundamental indicators, the technical analysis model makes it possible for you to check existing technical drivers of Vaxcyte, as well as the relationship between them.
Vaxcyte Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Vaxcyte, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to VaxcyteVaxcyte's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Vaxcyte Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 102.11 | Strong Buy | 10 | Odds |
Most Vaxcyte analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Vaxcyte stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Vaxcyte, talking to its executives and customers, or listening to Vaxcyte conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vaxcyte. If investors know Vaxcyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vaxcyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vaxcyte is measured differently than its book value, which is the value of Vaxcyte that is recorded on the company's balance sheet. Investors also form their own opinion of Vaxcyte's value that differs from its market value or its book value, called intrinsic value, which is Vaxcyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaxcyte's market value can be influenced by many factors that don't directly affect Vaxcyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaxcyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vaxcyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaxcyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vaxcyte 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Vaxcyte's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Vaxcyte.
| 10/29/2025 |
| 01/27/2026 |
If you would invest 0.00 in Vaxcyte on October 29, 2025 and sell it all today you would earn a total of 0.00 from holding Vaxcyte or generate 0.0% return on investment in Vaxcyte over 90 days. Vaxcyte is related to or competes with Crispr Therapeutics, Arrowhead Pharmaceuticals, PTC Therapeutics, Krystal Biotech, TG Therapeutics, Alkermes Plc, and Crinetics Pharmaceuticals. Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacte... More
Vaxcyte Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Vaxcyte's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Vaxcyte upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 2.51 | |||
| Information Ratio | 0.1036 | |||
| Maximum Drawdown | 15.14 | |||
| Value At Risk | (3.42) | |||
| Potential Upside | 6.38 |
Vaxcyte Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Vaxcyte's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Vaxcyte's standard deviation. In reality, there are many statistical measures that can use Vaxcyte historical prices to predict the future Vaxcyte's volatility.| Risk Adjusted Performance | 0.1031 | |||
| Jensen Alpha | 0.3114 | |||
| Total Risk Alpha | 0.0921 | |||
| Sortino Ratio | 0.1263 | |||
| Treynor Ratio | 0.3613 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Vaxcyte's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Vaxcyte January 27, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1031 | |||
| Market Risk Adjusted Performance | 0.3713 | |||
| Mean Deviation | 2.37 | |||
| Semi Deviation | 2.25 | |||
| Downside Deviation | 2.51 | |||
| Coefficient Of Variation | 768.69 | |||
| Standard Deviation | 3.06 | |||
| Variance | 9.33 | |||
| Information Ratio | 0.1036 | |||
| Jensen Alpha | 0.3114 | |||
| Total Risk Alpha | 0.0921 | |||
| Sortino Ratio | 0.1263 | |||
| Treynor Ratio | 0.3613 | |||
| Maximum Drawdown | 15.14 | |||
| Value At Risk | (3.42) | |||
| Potential Upside | 6.38 | |||
| Downside Variance | 6.28 | |||
| Semi Variance | 5.05 | |||
| Expected Short fall | (3.00) | |||
| Skewness | 0.3003 | |||
| Kurtosis | 0.4352 |
Vaxcyte Backtested Returns
Vaxcyte appears to be very steady, given 3 months investment horizon. Vaxcyte owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.12, which indicates the firm had a 0.12 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Vaxcyte, which you can use to evaluate the volatility of the company. Please review Vaxcyte's Semi Deviation of 2.25, risk adjusted performance of 0.1031, and Coefficient Of Variation of 768.69 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Vaxcyte holds a performance score of 9. The entity has a beta of 1.07, which indicates a somewhat significant risk relative to the market. Vaxcyte returns are very sensitive to returns on the market. As the market goes up or down, Vaxcyte is expected to follow. Please check Vaxcyte's treynor ratio, expected short fall, as well as the relationship between the Expected Short fall and day median price , to make a quick decision on whether Vaxcyte's existing price patterns will revert.
Auto-correlation | 0.00 |
No correlation between past and present
Vaxcyte has no correlation between past and present. Overlapping area represents the amount of predictability between Vaxcyte time series from 29th of October 2025 to 13th of December 2025 and 13th of December 2025 to 27th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Vaxcyte price movement. The serial correlation of 0.0 indicates that just 0.0% of current Vaxcyte price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 0.4 | |
| Residual Average | 0.0 | |
| Price Variance | 8.17 |
Vaxcyte technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Vaxcyte Technical Analysis
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Vaxcyte volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About Vaxcyte Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Vaxcyte on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Vaxcyte based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Vaxcyte price pattern first instead of the macroeconomic environment surrounding Vaxcyte. By analyzing Vaxcyte's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Vaxcyte's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Vaxcyte specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Current Ratio | 7.54 | 12.75 | 11.48 | 8.48 | Net Debt To EBITDA | 0.94 | 0.71 | 0.81 | 0.77 |
Vaxcyte January 27, 2026 Technical Indicators
Most technical analysis of Vaxcyte help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Vaxcyte from various momentum indicators to cycle indicators. When you analyze Vaxcyte charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.1031 | |||
| Market Risk Adjusted Performance | 0.3713 | |||
| Mean Deviation | 2.37 | |||
| Semi Deviation | 2.25 | |||
| Downside Deviation | 2.51 | |||
| Coefficient Of Variation | 768.69 | |||
| Standard Deviation | 3.06 | |||
| Variance | 9.33 | |||
| Information Ratio | 0.1036 | |||
| Jensen Alpha | 0.3114 | |||
| Total Risk Alpha | 0.0921 | |||
| Sortino Ratio | 0.1263 | |||
| Treynor Ratio | 0.3613 | |||
| Maximum Drawdown | 15.14 | |||
| Value At Risk | (3.42) | |||
| Potential Upside | 6.38 | |||
| Downside Variance | 6.28 | |||
| Semi Variance | 5.05 | |||
| Expected Short fall | (3.00) | |||
| Skewness | 0.3003 | |||
| Kurtosis | 0.4352 |
Vaxcyte January 27, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Vaxcyte stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.01 | ||
| Daily Balance Of Power | 1.00 | ||
| Rate Of Daily Change | 1.01 | ||
| Day Median Price | 53.07 | ||
| Day Typical Price | 53.18 | ||
| Price Action Indicator | 0.67 | ||
| Market Facilitation Index | 0.67 |
Additional Tools for Vaxcyte Stock Analysis
When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.